On the 3rd day of June, Shanghai Haohai Biological Technology Co., Ltd. (“Haohai Biological Technology”, Stock Code：6826.HK) held 2016 first domestic shareholders’ class meeting, 2016 first H shareholders’ class meeting and 2015 AGM in Shanghai on 09:30am, 10:00am and 10:30am respectively. This general meeting was chaired by Dr. Hong Yongtai, Chairman of Haohai Biological Technology and attended by senior management team, shareholder representatives and other representatives of the company under invitation.

 

All members of Haohai Biological Technology have made the best effort to maximize the values of shareholders in 2015 so as to realize the operating incomes for RMB 664 M, a year-on-year growth of 28.7%, gross operating profits for RMB 559 M, a year–on-year growth of 24.2%, net profits attributable to parent company’s shareholders for RMB 273 M, a year–on-year growth of 49%; and earnings per share for RMB 1.86, a year-on-year growth of 89.1%. The excellent performance attracted many investors to the scene of the meeting.

 

At the meeting, attending shareholders’ representatives have deliberated and voted on all work reports and proposals and all proposals submitted have been passed. Haohai Biological Technology believes, under the leadership of new board, supervisory board and management team, the company will definitely maintain moderate growth and make further development in the market environment featuring changeable policy.